Hcw Biologics Inc is a biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of cancer and immune-related diseases
The company's pipeline includes a range of biologic products that harness the body's immune system to target and destroy cancer cells, aiming to improve patient outcomes and enhance the quality of life for those affected by such conditions. Through advanced research and development, Hcw Biologics is committed to addressing significant medical needs in the oncology space and advancing personalized medicine.
Stay updated with the latest market activity on Monday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight.
Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session.
As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.
HCW Biologics shares are trading higher on Monday after the company announced clearance from the Food and Drug Administration for its Phase 1 trial of HCW9302.
HCW Biologics' stock rises as it partners with WY Biotech in an exclusive global license deal, securing $7 milion upfront and future potential milestone payments.
